Abstract:Abstract Background Cell metabolism, in addition to providing energy and biochemical building blocks, also regulates immune cell function. We have increased our understanding of how natural killer cells (NK cell) metabolism impacts human NK cell function; however, little is known about NK cell role and metabolic changes in autoimmune diseases. The dysfunctional NK cell phenotype observed in pathological settings linked to defective cell metabolism will give insights into the development of new therapies for inflammatory diseases. IBD is an autoimmune disease of unknown origin characterised by severe gut inflammation and increased risk of colorectal cancer. NK cells can augment autoimmune responses through their activation of adaptive immune response by interaction with macrophages, dendritic cells and T cells; therefore, it is essential to decipher NK cells function in IBD to propose novel therapeutic targets. In this study, we defined the phenotype and metabolic profile of NK cells isolated from peripheral blood of IBD patients. Methods Blood samples were obtained from healthy donors and IBD patients from whom written consent had been obtained. PBMC were isolated by Lymphoprep (Axis-Shield) gradient. PBMC were stained with a combination of cell surface receptors, intracellular cytokines, proteins and analysed by flow cytometry. Cells were either stained ex vivo or after overnight stimulation with cytokine combination IL-12 + IL-15 and in the presence or absence of mTORC1 inhibitor rapamycin. Changes in OxPhos or glycolysis were detected by XFp extracellular flux analyser (Agilent Technologies). Mitochondria mass and polarisation were measured by flow cytometry utilising MitoTracker Green and MitoTracker Red, respectively (ThermoFisher). Results NK cells from IBD patients have impaired mTORC1 activity (a key signalling pathway regulating cell metabolism), which is associated with increased expression of pro-inflammatory cytokines IL-17 and TNF-α. Patients NK cells have dysfunctional mitochondria characterised by reduced mitochondria mass, low membrane potential and limited OXPHOS and glycolysis. Furthermore, patients NK cells have limited IFNγ production, reduced TRAIL expression and defective capability of killing cancer cells. Conclusion Taken together, our results strongly imply that NK cells from IBD patients have a distinct bioenergetic programme that favours the increased production of pro-inflammatory cytokines. This might be an important unknown defect of NK cells in the regulation of inflammation in IBD that can be used for the development of new treatments. Further studies need to be conducted to identify the reason for the observed defects and determination of other key metabolic pathways involved in NK-cell function during IBD.

Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment

Enhanced IFN Sensing by Aggressive Chronic Lymphocytic Leukemia Cells

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.

Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression

Lipid Accumulation-Mediated Histone Hypoacetylation Drives Persistent NK Cell Dysfunction in Anti-Tumor Immunity

IL-10 Induces the Development of Immunosuppressive CD14 + HLA-DR Low/− Monocytes in B-cell Non-Hodgkin Lymphoma

Lipid Metabolism in Tumor-Associated Natural Killer Cells.

Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia

Tumorous Niche Drives Nk Exhaustion by Disordering Metabolic Program

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma

Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments

LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma

TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity

P104 Defective metabolism mediates NK cell dysfunction in inflammatory bowel disease (IBD)

Increased Infiltration of Macrophages to Radioresistant Lung Cancer Cells Contributes to the Development of the Additional Resistance of Tumor Cells to the Cytotoxic Effects of NK Cells.

Inflammation perturbs NK cell phenotype and function in chronic myeloid leukemia (CML)

Impaired Lipid Biosynthesis Hinders Anti-Tumor Efficacy Of Intratumoral Inkt Cells

Activated B cells suppress T-cell function through metabolic competition